Abhishek K. Srivastava - 12 Aug 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Vice President, Techncial Operations
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
12 Aug 2022
Net transactions value
$0
Form type
4
Filing time
16 Aug 2022, 17:00:41 UTC
Previous filing
15 Aug 2022
Next filing
19 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +250,000 $0.000000 250,000 12 Aug 2022 Common Stock 250,000 $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares underlying the options vest on August 3, 2023, and with respect to the remainder, in twelve successive equal quarterly installments measured from August 3, 2023, subject to the Reporting Person's continued service through each such date.

Remarks:

Vice President, Techncial Operations